{"id":3709,"date":"2025-12-01T19:03:54","date_gmt":"2025-12-01T19:03:54","guid":{"rendered":"http:\/\/blog.valuengine.com\/?p=3709"},"modified":"2025-12-01T19:07:13","modified_gmt":"2025-12-01T19:07:13","slug":"12-1-2025-valuengine-weekly-market-summary-commentary","status":"publish","type":"post","link":"http:\/\/blog.valuengine.com\/index.php\/12-1-2025-valuengine-weekly-market-summary-commentary\/","title":{"rendered":"12\/1\/2025 ValuEngine Weekly Market Summary & Commentary"},"content":{"rendered":"

Weekly Market Recap – Week Ending November 28, 2025<\/strong><\/p>\n

Market action during Thanksgiving week delivered a broad-based rebound across U.S. equities. Nearly every ETF in our coverage list finished higher, led by strong gains in small caps (VB<\/strong> +3.64%), consumer discretionary (XLY<\/strong> +3.48%), and materials (XLB<\/strong> +3.33%). Large-cap growth also participated, with QQQM<\/strong> rising 2.31% and SPYM<\/strong> advancing 2.10%, signaling renewed investor appetite for risk assets after a difficult start to the month.<\/div>\n

<\/h4>\n
In the below table we use major ETF\u2019s as a proxy for some major indexes as well as each of the sector groups into which we divide the overall markets. Tracking these over time provides a more defined picture of the US markets than simply tracking major indexes.<\/div>\n

<\/h4>\n
Free Trial: Research on over 5,000 stocks and 700 ETFs HERE<\/a><\/div>\n

<\/h4>\n
<\/div>\n
\"\"<\/div>\n
<\/div>\n

<\/h4>\n
\"\"<\/div>\n
<\/div>\n
\n

Trade ValuEngine designed portfolio strategies, www.ValuEngineCapital.com<\/a><\/p>\n<\/div>\n

Strategy Note:<\/strong><\/div>\n
\n
\n

What a difference a week makes! In last week\u2019s update, we documented empirically that the story of November 2025 thus far was rotation from mega-cap tech and growth stocks to value stocks. The Invesco Nasdaq-100 ETF, QQQM<\/strong>, and the SPDR S&P 500 ETF, SPYM<\/strong>, were both deep into negative territory.<\/p>\n

Upsetting the narrative, Thanksgiving week was one that \u201cmega-tech\u201d should be thankful for. Both large-cap ETFs were up every day. This recovery shaved the decline on QQQM<\/strong> to a mere 1.6% on the month while SPYM<\/strong> fell just 0.5%. Foreign markets had similar shavings of earlier declines for the month. EEM<\/strong>, the iShares MSCI Emerging Markets ETF, lost just 1.6% while the loss for the month in developed markets on the iShares MSCI EAFE<\/strong> ETF was just 0.2%. Value still was the US winner for the month with VTV<\/strong>, Vanguard Value ETF, gaining 1.6% while Vanguard Utilities ETF rose 0.5%. IBIT<\/strong> also shaved its \u221223% decline to \u221219% for the month, not enough to save it from being called Black October by Bitcoin traders. Untouched by this reversal was gold as GLDM<\/strong>, SPDR Gold MiniShares Trust, continued to outclimb everything with a 3.4% gain.<\/p>\n

Most strategists see last week as the start of the proverbial Santa Claus rally and given that the month of December has generally been a good month to own stocks, we would tend to agree. The opinions are more mixed on whether large-cap growth will continue to lead. In terms of our ETF ratings, our models are in the large-cap camp. QQQM<\/strong> is rated 5 (Strong Buy) with SPYM<\/strong> rated 4 (Buy). Our prediction model is still bullish on NVDA<\/strong> despite its high volatility, with a 5 rating. Most of the other top six stocks in the S&P 500 are rated 4 including Microsoft (MSFT<\/strong>), Amazon (AMZN<\/strong>), Broadcom (AVGO<\/strong>), and Alphabet (GOOGL<\/strong>).<\/p>\n

Interestingly, although our model doesn\u2019t like small-cap standard bearer IWM<\/strong>, the iShares Russell 2000 Small Cap ETF (rated 2), it loves its largest 10 holdings. Eight of the 10 are rated either Buy or Strong Buy. This list includes Credo Tech (CRDO<\/strong>), Nextracker (NXT<\/strong>), Guardian Health (GH<\/strong>), and Madrigal Pharmaceutical (MDGL<\/strong>), all rated 5. The 4-rated stocks include Bloom Energy (BE<\/strong>), Fabrinet (FN<\/strong>), Kratos Defense (KTOS<\/strong>), and BridgeBio Pharmaceutical (BBIO<\/strong>).<\/p>\n

Similarly, we rate Vanguard Value ETF (VTV<\/strong>) at 3 (Hold) but three of the top 10 stocks are rated 4: JP Morgan Chase (JPM<\/strong>), Johnson & Johnson (JNJ<\/strong>), and BankAmerica (BAC<\/strong>). There are a number of other low P\/E stocks that are considered relatively undervalued by our valuation model and rated 4 or 5. These include UBS Group (UBS<\/strong>), CVS Corp. (CVS<\/strong>), Coca-Cola (KO<\/strong>), Anheuser-Busch ADR (BUD<\/strong>), Mitsubishi ADR (MUFG<\/strong>), Novartis ADR (NVS<\/strong>), and CME Group (CME<\/strong>). On the flip side, the one stock in the top 10 of VTV<\/strong> rated 2 (Sell) is United Healthcare (UNH<\/strong>).<\/p>\n

Finally, since \u2019tis the retail season, one retail stock that is rated 5 is ERMENEGILDO ZEGNA (ZGN<\/strong>), the luxury designer.<\/p>\n

 <\/p>\n<\/div>\n

www.ValuEngine.com<\/a>\u00a0(Valuengine, Inc) is a stock valuation and forecasting service founded by Ivy League finance academics. VE utilizes the most advanced quantitative techniques and analysis available to analyze over 4,200 US stocks, 700 US ETFs, and 1,000 Canadian stocks. Fair market valuations, forecasted target prices, and buy\/hold\/sell recommendations are updated DAILY.<\/p>\n

www.ValuEngineCapital.com<\/a>\u00a0(ValuEngine Capital Management, LLC) is a Registered Investment Advisory firm that trades a variety of different portfolios based upon the ValuEngine.com research models. Each portfolio has a different risk\/return profile, so clients can be placed in strategies that fit their specific investment needs.<\/p>\n

BLOG.VALUENGINE.COM\u00a0<\/a>for the full history of ValuEngine.com financial blog posts<\/p>\n

____________________________________________________________________________<\/p>\n

Existing subscribers alert: ValuEngine has launched a completely redesigned and new website! Please check it out at\u00a0www.Valu<\/a>E<\/a>ngine.com<\/a><\/p>\n

Free trials available for new subscribers. Over 4,200 stocks and 600 ETFs covered.<\/p>\n

Full Two Week Free Trial\u00a0HERE<\/a><\/p>\n

5,000 stocks, 600 ETFs, 16 sector groups, and 140 industries updated on\u00a0www.ValuEngine.com<\/a>.<\/p>\n

Financial Advisory Services based on ValuEngine research available through\u00a0www.ValuEngineCapital.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Weekly Market Recap – Week Ending November 28, 2025 Market action during Thanksgiving week delivered a broad-based rebound across U.S. equities. Nearly every ETF in our coverage list finished higher, led by strong gains in small caps (VB +3.64%), consumer discretionary (XLY +3.48%), and materials (XLB +3.33%). Large-cap growth also participated, with QQQM rising 2.31% … Read more<\/a><\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[130,1,39],"tags":[469,2645,2696,2690,31,2647,2695,2678,1002,2732,2846,2847,2723,2726,1374,2850,1366,2776,2834,2837,2500,2515,1135,2848,2838,2720,1760,1761,81,2844,2841,2842,1776,2635,2644,1731,2316,1834,2815,2817,59,2816,1426,2849,262,2845,2832,2835,1819,2729,1543,934,2843,1198,2646,2851,2665,77,2642,2852,2853,2839,2840,2006,1510,1938,2833,2836,1748,2801,1712,1699,1687,928,2812,1017,2658,57,2854,28,1659,2831,2356,2462,2121,2085,2277,1849,2279,1887,1814,2707,1900,2276,2278,2855,2856],"_links":{"self":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/3709"}],"collection":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/comments?post=3709"}],"version-history":[{"count":7,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/3709\/revisions"}],"predecessor-version":[{"id":3718,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/3709\/revisions\/3718"}],"wp:attachment":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/media?parent=3709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/categories?post=3709"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/tags?post=3709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}